Epithelial responses to rotavirus induced purinergic signaling
上皮对轮状病毒诱导的嘌呤信号的反应
基本信息
- 批准号:10665537
- 负责人:
- 金额:$ 5.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-12-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:5 year oldAgonistAnimal ModelApicalBody Weight decreasedCalciumCalcium OscillationsCalcium SignalingCell LineCellsCessation of lifeChildChildhoodChloride ChannelsChloridesClustered Regularly Interspaced Short Palindromic RepeatsCytoplasmic GranulesDataDehydrationDeveloping CountriesDevelopmentDiarrheaDistantDysenteryEnteralEnterocytesEpithelial CellsEpitheliumEventFluids and SecretionsFoundationsFunctional disorderGastrointestinal PhysiologyGenerationsGeneticGoalsGoblet CellsHistologicHistopathologyHumanITPR1 geneImageImmune responseIn VitroInfectionIntestinesKnock-outKnowledgeLifeLiquid substanceLocationMediatingMolecularMorbidity - disease rateMorphologyMucinsMucous body substanceMusOral Rehydration TherapyOrganoidsParacrine CommunicationPathogenesisPathway interactionsPharmacotherapyPhysiologyPlayPredispositionProductionPurine NucleotidesReporterResearchResolutionRoleRotavirusRotavirus InfectionsSignal PathwaySignal TransductionSmall IntestinesSupportive careSymptomsSystemTherapeutic AgentsVaccinesVillusVirusVirus SheddingVomitingcell motilitycell typecytokinediarrheal diseaseexperimental studyextracellularglobal healthimprovedin vivoinhibitorinsightintercellular communicationintestinal epitheliumintestinal villimortalitymouse modelnew therapeutic targetnovelnovel therapeuticsparacrinepharmacologicpurinoceptor P2Y1responsesobrietystatisticstargeted treatmentvaccine access
项目摘要
PROJECT SUMMARY
Pediatric diarrheal diseases are a major cause of morbidity in children under 5 years old. Rotavirus is an enteric
virus that causes diarrhea and vomiting and can be fatal in children without supportive care. Rotavirus infection
results in 128,500 deaths per year. Despite causing severe, potentially life-threatening diarrhea, rotavirus
infection is highly localized to the enterocytes in the villus tips of the small intestine. Until recently, it was unclear
how these cell-cell signals were propagated from infected cells to surrounding uninfected cells. Using high
resolution live imaging, we found that rotavirus infection increases calcium (Ca2+) signaling both within infected
enterocytes as well as surrounding uninfected cells, which manifests as intercellular Ca2+ waves. These Ca2+
waves originate from the infected cell and propagate through uninfected cells. We have identified that Ca2+ waves
are mediated by extracellular purinergic signaling; primarily through the purine nucleotide ADP and the P2Y1
receptor. However, the functional consequence of these intercellular Ca2+ waves remains unknown. Our central
hypothesis is that rotavirus-induced paracrine signaling, via P2Y1 purinergic signaling, functionally
dysregulates neighboring uninfected epithelium response and is required for the hallmarks of rotavirus
infection. Potential downstream targets of P2Y1 signaling include chloride (Cl-) and mucin secretion. Rotavirus
infection is characterized by both Cl- driven secretory diarrhea and loss of mucin-filled goblet cells; hallmarks
which are considered to promote infection. We are focusing on rotavirus-epithelial interactions as these events
may be able to mediate the major consequence of infection. The objective of this research is to elucidate the
role of purinergic signaling in host intestinal epithelial cells in response to rotavirus infection and the mechanistic
consequences of rotavirus dysregulation of these pathways. Aim 1 will determine the role of purinergic signaling
via P2Y1 during rotavirus infection in vivo. We anticipate deficiency of P2Y1, by genetic loss of P2Y1 (P2Y1-/-
mice) or inhibition of P2Y1 with the pharmacological inhibitor MRS2500, will reduce rotavirus symptoms including
decreased diarrhea, weight loss, histopathology and cytokine production, and viral shedding. In Aim 2 we will
characterize the signaling pathways in vitro that drive epithelial functions (cell susceptibility, Cl- secretion, and
mucus expulsion) during rotavirus infection in human intestinal enteroids (HIEs). We predict that pretreatment of
HIEs with ADP or P2Y1 agonist increases susceptibility to infection and results in increased infected cells, apical
Cl- secretion and fluid secretion. We anticipate ADP activation of P2Y1 stimulations Ca2+ activated chloride
channels (CaCC) via PLC and IP3R, which also plays a role in mucin secretion from goblet cells. We will use
fluorescent reporters, pharmacological inhibitors and P2Y1 and P2Y2 CRISPR knockout HIEs to identify these
epithelial signaling cascades. This study will provide the first evidence for purinergic signaling in epithelial cells
in the context of rotavirus infection. Collectively, these experiments will enhance our knowledge of rotavirus
pathophysiology and may provide insight for novel therapeutic targets.
项目概要
小儿腹泻病是 5 岁以下儿童发病的主要原因。轮状病毒是一种肠道病毒
该病毒会导致腹泻和呕吐,如果没有支持性护理,可能会导致儿童死亡。轮状病毒感染
每年导致 128,500 人死亡。尽管轮状病毒会引起严重的、可能危及生命的腹泻,
感染高度集中于小肠绒毛尖端的肠细胞。直到最近还不清楚
这些细胞间信号如何从受感染的细胞传播到周围未受感染的细胞。使用高
分辨率实时成像,我们发现轮状病毒感染会增加感染体内的钙 (Ca2+) 信号传导
肠上皮细胞以及周围未感染的细胞,表现为细胞间 Ca2+ 波。这些Ca2+
波源自受感染的细胞并通过未受感染的细胞传播。我们已经确定 Ca2+ 波
由细胞外嘌呤能信号介导;主要通过嘌呤核苷酸ADP和P2Y1
受体。然而,这些细胞间 Ca2+ 波的功能后果仍然未知。我们的中央
假设是轮状病毒诱导的旁分泌信号通过 P2Y1 嘌呤能信号在功能上发挥作用
失调邻近未感染的上皮反应,并且是轮状病毒特征所必需的
感染。 P2Y1 信号传导的潜在下游靶标包括氯 (Cl-) 和粘蛋白分泌。轮状病毒
感染的特征是氯驱动的分泌性腹泻和充满粘蛋白的杯状细胞的损失;标志
这被认为会促进感染。我们关注轮状病毒与上皮细胞的相互作用,因为这些事件
可能能够介导感染的主要后果。这项研究的目的是阐明
宿主肠上皮细胞嘌呤信号对轮状病毒感染的反应及其机制
轮状病毒对这些途径失调的后果。目标 1 将确定嘌呤能信号传导的作用
在体内轮状病毒感染期间通过P2Y1。我们预计 P2Y1 会因 P2Y1 的遗传缺失而缺乏 (P2Y1-/-
小鼠)或用药理学抑制剂 MRS2500 抑制 P2Y1,将减轻轮状病毒症状,包括
腹泻、体重减轻、组织病理学和细胞因子产生以及病毒脱落减少。在目标 2 中,我们将
表征驱动上皮功能的体外信号通路(细胞敏感性、Cl-分泌和
人肠肠类(HIE)轮状病毒感染期间的粘液排出)。我们预测预处理
具有 ADP 或 P2Y1 激动剂的 HIE 会增加感染的易感性,并导致感染细胞增多,顶端
Cl-分泌和液体分泌。我们预计 ADP 激活 P2Y1 刺激 Ca2+ 活化氯化物
通过 PLC 和 IP3R 的通道(CaCC),它也在杯状细胞的粘蛋白分泌中发挥作用。我们将使用
荧光报告基因、药理学抑制剂以及 P2Y1 和 P2Y2 CRISPR 敲除 HIE 来识别这些
上皮信号级联反应。这项研究将为上皮细胞中嘌呤能信号传导提供第一个证据
在轮状病毒感染的情况下。总的来说,这些实验将增强我们对轮状病毒的了解
病理生理学,并可能为新的治疗靶点提供见解。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Bioinformatics reveal elevated levels of Myosin Vb in uterine corpus endometrial carcinoma patients which correlates to increased cell metabolism and poor prognosis.
- DOI:10.1371/journal.pone.0280428
- 发表时间:2023
- 期刊:
- 影响因子:3.7
- 作者:Engevik, Kristen A.;Engevik, Melinda A.;Engevik, Amy C.
- 通讯作者:Engevik, Amy C.
Myosin 5b is required for proper localization of the intermicrovillar adhesion complex in the intestinal brush border.
肌球蛋白 5b 是微绒毛间粘附复合物在肠刷状缘正确定位所必需的。
- DOI:10.1152/ajpgi.00212.2022
- 发表时间:2022
- 期刊:
- 影响因子:0
- 作者:Dooley,SarahA;Engevik,KristenA;Digrazia,Jessica;Stubler,Rachel;Kaji,Izumi;Krystofiak,Evan;Engevik,AmyC
- 通讯作者:Engevik,AmyC
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kristen Engevik其他文献
Kristen Engevik的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kristen Engevik', 18)}}的其他基金
Epithelial responses to rotavirus induced purinergic signaling
上皮对轮状病毒诱导的嘌呤信号的反应
- 批准号:
10313481 - 财政年份:2021
- 资助金额:
$ 5.19万 - 项目类别:
Elucidating the mechanism behind TFF2-mediated gastric restitution
阐明 TFF2 介导的胃恢复背后的机制
- 批准号:
9396272 - 财政年份:2017
- 资助金额:
$ 5.19万 - 项目类别:
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 5.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 5.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 5.19万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 5.19万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 5.19万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 5.19万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 5.19万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 5.19万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 5.19万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 5.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




